Jean-Pierre Routy has dedicated the last two decades bringing science and treatment innovation to help combat the health challenges of HIV/AIDS care. His fight in health and AIDS related malignancies has led him to obtain the McGill University Louis Lowenstein Chair in Hematology & Oncology. He is an attending physician in the Division of Hematology and Chronic Viral Illness Service at the Royal Victoria Hospital and Professor in the department of Medicine and Experimental Medicine at McGill University, Montreal Canada.
After completing his training in Medicine and Hematology-Oncology at University Aix-Marseille in 1986, he obtained a Postdoctoral Research Fellow Award from the Canadian HIV Trials Network (CTN) and became Assistant Professor in the Department of Medicine at the University of Montreal. In 1994, Doctor Routy joined McGill University and was promoted Associate Professor and co-director of the Flow Cytometry Laboratory at the Royal Victoria Hospital. In addition to his clinical research, he was awarded Chair of the Royal Victoria Hospital Ethics Committee.
As an FRSQ Clinician-Scientist, he was able to implement the Montreal Primary HIV-Infection cohort, which generated important findings in HIV pathogenesis and drug resistance. His achievements have led Dr. Routy to become the National Co-Director of the Immunotherapy and Vaccine Core at the Canadian Health Research Institutes for HIV Trials Network. Since 2011, he co-chairs the Eradication Clinical Working Group for the International AIDS Society. Doctor Routy was co-chair of the 2012 Canadian Association for HIV/AIDS Research Conference.
Doctor Routy has authored or co-authored over 180 peer-reviewed publications including articles in journals such as: New England Journal of Medicine, The Lancet, Nature Medicine, Blood and AIDS, he also authored a book entitled “What AIDS has changed” for which he won a literary award from the Ottawa Saint Paul University.